Evidence map›Paper›PMID 27780885›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2017

FutureTox III: Bridges for Translation.

Daland R Juberg, Thomas B Knudsen, Miriam Sander, Nancy B Beck, Elaine M Faustman, Donna L Mendrick, John R Fowle, Thomas Hartung, Raymond R Tice, Emmanuel Lemazurier and 10 more

Abstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. FutureTox IV Workshop Summary: Predictive Toxicology for Healthy Children.Toxicological sciences : an official journal of the Society of Toxicology · 2021
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Programming microphysiological systems for children's health protection.Experimental biology and medicine (Maywood, N.J.) · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Daland R JubergDow AgroSciences, Indianapolis, Indiana; drjuberg@dow.com.
Thomas B KnudsenUS Environmental Protection Agency, Research Triangle Park, North Carolina.
Miriam SanderPage One Editorial Services, Boulder, Colorado.
Nancy B BeckAmerican Chemistry Council, Washington, The District of Columbia.
Elaine M FaustmanUniversity of Washington, Seattle, Washington.
Donna L MendrickUS Food and Drug Administration, Silver Spring, Maryland.
John R FowleScience to Inform, LLC, Pittsboro, North Carolina.
Thomas HartungJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Raymond R TiceNational Toxicology Program/National Institute of Environmental Health Sciences, Durham, North Carolina.
Emmanuel LemazurierINERIS-Chronic Risk Division, Verneeuil-en-Halatte, France.
Richard A BeckerAmerican Chemistry Council, Washington, The District of Columbia.
Suzanne Compton FitzpatrickUS Food and Drug Administration, College Park, Maryland.
George P DastonProcter & Gamble Company, Cincinnati, Ohio.
Alison HarrillUniversity of Arkansas for Medical Sciences, Little Rock, Arkansas.
Ronald N HinesUS Environmental Protection Agency, Research Triangle Park, North Carolina.
Douglas A KellerSanofi, Bridgewater, New Jersey.
John C LipscombUS Environmental Protection Agency, Cincinnati, Ohio.
David WatsonLhasa Limited, Leeds, United Kingdom.
Tina BahadoriUS Environmental Protection Agency, Washington, The District of Columbia.
Kevin M CroftonUS Environmental Protection Agency, Research Triangle Park, North Carolina.

Funding

Biomolecular Screening and Alternative Approaches for the National Toxicology ProgramZIAES103318 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI CASEY, WARREN · 2016 to 2021
$25.0M
6 · The paper itself

Abstract

Future Tox III, a Society of Toxicology Contemporary Concepts in Toxicology workshop, was held in November 2015. Building upon Future Tox I and II, Future Tox III was focused on developing the high throughput risk assessment paradigm and taking the science of in vitro data and in silico models forward to explore the question-what progress is being made to address challenges in implementing the emerging big-data toolbox for risk assessment and regulatory decision-making. This article reports on the outcome of the workshop including 2 examples of where advancements in predictive toxicology approaches are being applied within Federal agencies, where opportunities remain within the exposome and AOP domains, and how collectively the toxicology community across multiple sectors can continue to bridge the translation from historical approaches to Tox21 implementation relative to risk assessment and regulatory decision-making.

Indexed as

ToxicologyAnimalsHumansIn Vitro TechniquesToxicity Testsin vitro and alternativespredictive toxicologyregulatory/policyrisk assessmenttesting alternatives.

Identifiers

PMID27780885
PMCPMC6080854

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.